PS | Location | ER | RT field | Dose | Recurrence site | DFS | Treatment for recurrence |
---|---|---|---|---|---|---|---|
0 | Mt | − | ENI | 60.0 | Local | 0 | Surgery |
1 | Mt | + | ENI | 28.0 | Lung | 6.1 | Surgery |
0 | Ut | − | Non-ENI | 40.0 | Local | 7.2 | ESD |
0 | Mt | + | ENI | 40.0 | #104R | 13.1 | Chemotherapy |
0 | Lt | + | ENI | 39.6 | #3, #7 | 15.3 | Surgery |
0 | Ut | + | ENI | 50.4 | #101R | 19.8 | Chemotherapy |
0 | Mt | + | ENI | 40.0 | #109R | 22.5 | Chemotherapy |
0 | Mt | + | ENI | 39.6 | #104R | 28.5 | Chemotherapy |
0 | Mt | + | ENI | 65.0 | #104R | 30.7 | Chemotherapy |
0 | Mt | + | Non-ENI | 40.0 | #104R | 31.0 | Chemotherapy |
0 | Mt | + | ENI | 39.6 | Local | 43.2 | ESD |
1 | Lt | − | Non-ENI | 65.0 | #106recR | 58.3 | Chemotherapy |
0 | Mt | + | ENI | 40.0 | Local | 75.1 | ESD |